Pharmaceutical

India’s Cipla signs licence deal with Novartis for diabetes drug Galvus

India’s Cipla signs licence deal with Novartis for diab...

Apr 10, 2023

Cipla will be responsible for the manufacturing and marketing of Galvus and its ...

Australia lists new medicines for GVHD and chronic rhinosinusitis

Australia lists new medicines for GVHD and chronic rhin...

Apr 10, 2023

Jakavi is expected to benefit 225 patients with acute or chronic graft versus ho...

mRNA vaccine for cancer along with Keytruda obtains PRIME designation

mRNA vaccine for cancer along with Keytruda obtains PRI...

Apr 10, 2023

The PRIME regulatory mechanism provides support for the development of medicines...

Competing abortion pill rulings sow broad alarm, confusion

Competing abortion pill rulings sow broad alarm, confusion

Apr 9, 2023

Competing rulings on the abortion pill from judges in Texas and Washington on th...

FDA warns some Philips respirators may not deliver the right treatment

FDA warns some Philips respirators may not deliver the ...

Apr 9, 2023

Some Philips respirators were incorrectly programmed with the wrong serial numbe...

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

This biotech could one day make human eggs from scratch...

Apr 9, 2023

Biotech startup Gameto is trying to boosting the odds of success in IVF by creat...

FDA withdraws approval of preterm birth drug Makena

FDA withdraws approval of preterm birth drug Makena

Apr 8, 2023

The decision means that the only approved drug to reduce premature birth risk ca...

Enanta secures FDA fast track designation for EDP-323 to treat RSV

Enanta secures FDA fast track designation for EDP-323 t...

Apr 8, 2023

EDP-323 showed reduction in RSV replication with potency in primary human bronch...

Moderna’s mRNA vaccine along with Keytruda obtains PRIME designation

Moderna’s mRNA vaccine along with Keytruda obtains PRIM...

Apr 8, 2023

The PRIME regulatory mechanism provides support for the development of medicines...

UK’s NICE recommends AstraZeneca’s olaparib to treat cancer types

UK’s NICE recommends AstraZeneca’s olaparib to treat ca...

Apr 8, 2023

The latest decision by NICE reverses its earlier draft decision not to recommend...

Abbott glucose monitor readers could catch fire, FDA warns in recall notice

Abbott glucose monitor readers could catch fire, FDA wa...

Apr 7, 2023

Abbott has recalled millions of readers for its FreeStyle Libre glucose monitors...

Telehealth’s new weight loss drug pitch, a crackdown on AI to deny care, and Boston Scientific enters obesity treatment area

Telehealth’s new weight loss drug pitch, a crackdown on...

Apr 7, 2023

In the latest edition of STAT's Health Tech newsletter: telehealth's new weight ...

Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case

Genentech review of Tessier-Lavigne paper finds no evid...

Apr 7, 2023

A Genentech internal review of misconduct allegations concerning a landmark pape...

STAT+: Brazilian government advisory committee says a Vertex cystic fibrosis drug is not cost-effective and should not be reimbursed

STAT+: Brazilian government advisory committee says a V...

Apr 7, 2023

A Brazilian government advisory committee recommended that the health ministry n...

Listen: Illumina’s boardroom intrigue, the next big Alz...

Apr 7, 2023

Is Illumina the Disney of biotech? Does the Texas two-step work after all? And c...

STAT+: FDA withdraws approval of controversial drug to prevent preterm births

STAT+: FDA withdraws approval of controversial drug to ...

Apr 7, 2023

After a years-long controversy, the FDA has ordered the immediate withdrawal of ...